IRIS Accounts Production v23.4.0.336 10873717 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh108737172022-07-31108737172023-07-31108737172022-08-012023-07-31108737172021-07-31108737172021-08-012022-07-31108737172022-07-3110873717ns15:EnglandWales2022-08-012023-07-3110873717ns14:PoundSterling2022-08-012023-07-3110873717ns10:Director12022-08-012023-07-3110873717ns10:PrivateLimitedCompanyLtd2022-08-012023-07-3110873717ns10:SmallEntities2022-08-012023-07-3110873717ns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3110873717ns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3110873717ns10:SmallCompaniesRegimeForAccounts2022-08-012023-07-3110873717ns10:FullAccounts2022-08-012023-07-3110873717ns10:Director22022-08-012023-07-3110873717ns10:RegisteredOffice2022-08-012023-07-3110873717ns5:CurrentFinancialInstruments2023-07-3110873717ns5:CurrentFinancialInstruments2022-07-3110873717ns5:ShareCapital2023-07-3110873717ns5:ShareCapital2022-07-3110873717ns5:RetainedEarningsAccumulatedLosses2023-07-3110873717ns5:RetainedEarningsAccumulatedLosses2022-07-3110873717ns5:PlantMachinery2022-08-012023-07-3110873717ns5:PlantMachinery2022-07-3110873717ns5:PlantMachinery2023-07-3110873717ns5:PlantMachinery2022-07-3110873717ns5:CostValuation2022-07-3110873717ns5:AdditionsToInvestments2023-07-3110873717ns5:CostValuation2023-07-3110873717ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3110873717ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-07-31
REGISTERED NUMBER: 10873717 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 July 2023

for

David Woolf Oncology Ltd

David Woolf Oncology Ltd (Registered number: 10873717)






Contents of the Financial Statements
for the Year Ended 31 July 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


David Woolf Oncology Ltd

Company Information
for the Year Ended 31 July 2023







DIRECTORS: Dr D K Woolf
Mrs D R Woolf





REGISTERED OFFICE: 7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP





REGISTERED NUMBER: 10873717 (England and Wales)





ACCOUNTANTS: Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP

David Woolf Oncology Ltd (Registered number: 10873717)

Balance Sheet
31 July 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 31,798 42,830
Investments 5 43,536 10,214
75,334 53,044

CURRENT ASSETS
Debtors 6 14,986 56,699
Cash at bank 237,011 207,033
251,997 263,732
CREDITORS
Amounts falling due within one
year

7

126,836

117,633
NET CURRENT ASSETS 125,161 146,099
TOTAL ASSETS LESS CURRENT
LIABILITIES

200,495

199,143

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 200,395 199,043
200,495 199,143

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

David Woolf Oncology Ltd (Registered number: 10873717)

Balance Sheet - continued
31 July 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2024 and were signed on its behalf by:





Dr D K Woolf - Director


David Woolf Oncology Ltd (Registered number: 10873717)

Notes to the Financial Statements
for the Year Ended 31 July 2023

1. STATUTORY INFORMATION

David Woolf Oncology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents trading income accrued during the period shown by these financial statements.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% Straight Line and 25% Reducing Balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

David Woolf Oncology Ltd (Registered number: 10873717)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 August 2022
and 31 July 2023 57,979
DEPRECIATION
At 1 August 2022 15,149
Charge for year 11,032
At 31 July 2023 26,181
NET BOOK VALUE
At 31 July 2023 31,798
At 31 July 2022 42,830

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 August 2022 10,214
Additions 33,322
At 31 July 2023 43,536
NET BOOK VALUE
At 31 July 2023 43,536
At 31 July 2022 10,214

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 14,986 56,699

David Woolf Oncology Ltd (Registered number: 10873717)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors - (1 )
Taxation and social security 23,694 24,414
Other creditors 103,142 93,220
126,836 117,633